NCT01364064View on ClinicalTrials.gov

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

PHASE3CompletedINTERVENTIONAL

Enrollment

1,153

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Glioblastoma

Interventions

DRUG

TMZ

Comparing conventional adjuvant Temozolomide with dose intensive Temozolomide

All Listed Sponsors

collaborator

Radiation Therapy Oncology Group

NETWORK

lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT01364064 - Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma | Biotech Hunter | Biotech Hunter